PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|March 18, 2020
Standardized Tablet Coater Offers Cost-Efficiency
Advertisement
Lödige Process Technology introduced the LC light series of tablet coaters that use as standardized design to provide cost-efficient models with faster delivery times than its customized LC series.
The new coater model uses the key technologies found in the LC series, including the air-guiding system, nozzles made by Düsen-Schlick, and a nozzle arm that permits adaptation of the nozzle position to the tablet bed. In the air-guiding system, air flows through a distributor pipe and around the coater drum, entering the drum along a large circumference, which creates an even, low-turbulence air flow in the coater to optimize coating. It also prevents contamination in the coater interior, on the nozzles, or on the nozzle arm. The nozzle arm adjustability allows users to optimize the spraying distance and angle at any time.
Source:
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement